AstraZeneca announces withdrawal of its Covid-19 vaccine from the market

British pharmaceutical company AstraZeneca announced the withdrawal of its popular vaccine once morest the pandemic from covid-19ensuring that The demand for vaccines on the market has gradually decreased.

The drug, developed in collaboration with the University of Oxford, was one of the main elements in the health sector during the arrival and impact of the Covid-19 pandemic.

Total, More than 3 billion doses were supplied of the AstraZeneca vaccine, which began to be administered in January 2021.

However, the company indicated that The drug has not generated revenue since April 2023.

“As multiple variant vaccines for Covid-19 have been developed (…), there is a surplus of updated vaccines available. This has led to a decline in demand for Vaxzevria, which is no longer manufactured or supplied”explained to CNN the company. “AstraZeneca has therefore taken the decision to initiate the withdrawal of marketing authorisations for Vaxzevria in Europe.”

The fact implies that The vaccine is not authorized to be marketed or sold in countries of the European Union..

In other territories, the British pharmaceutical company will seek a way forward for the gradual withdrawal of its product. “We are incredibly proud of the role Vaxzevria has played… Our efforts have been recognized by governments around the world and are widely regarded as a critical component in ending the global pandemic.”the company said in a statement.